{"slideshow_credits": null, "snippet": "Federal lawmakers were late to respond to the problem, but at least they seem prepared to open more paths to treatment.", "abstract": "Editorial lauds Congress for introducing legislation aimed at countering opioid epidemic, which caused over 28,000 deaths in 2014; argues federal and state governments must invest in robust prevention and treatment programs; calls for looser restrictions on prescribing buprenorphine, which has helped wean addicts from stronger drugs.", "section_name": "Opinion", "print_page": "22", "document_type": "article", "byline": {"person": [], "original": "By THE EDITORIAL BOARD", "organization": "THE EDITORIAL BOARD"}, "web_url": "http://www.nytimes.com/2016/05/16/opinion/congress-wakes-up-to-the-opioid-epidemic.html", "lead_paragraph": "Federal lawmakers were late to respond to the problem, but at least they seem prepared to open more paths to treatment.", "headline": {"print_headline": "Congress Wakes Up to the Opioid Epidemic", "main": "Congress Wakes Up to the Opioid Epidemic", "content_kicker": "Editorial", "kicker": "Editorial"}, "_id": "573974f638f0d83bc1f1637d", "word_count": "665", "multimedia": [{"height": 126, "url": "images/2016/05/16/opinion/sunday/16mon2/16mon2-thumbWide.jpg", "legacy": {"wideheight": "126", "wide": "images/2016/05/16/opinion/sunday/16mon2/16mon2-thumbWide.jpg", "widewidth": "190"}, "subtype": "wide", "width": 190, "type": "image"}, {"height": 772, "url": "images/2016/05/16/opinion/sunday/16mon2/16mon2-articleLarge.jpg", "legacy": {"xlarge": "images/2016/05/16/opinion/sunday/16mon2/16mon2-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "772"}, "subtype": "xlarge", "width": 600, "type": "image"}, {"height": 75, "url": "images/2016/05/16/opinion/sunday/16mon2/16mon2-thumbStandard.jpg", "legacy": {"thumbnail": "images/2016/05/16/opinion/sunday/16mon2/16mon2-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2016-05-16T00:00:00Z", "source": "The New York Times", "news_desk": "Editorial", "keywords": [{"name": "subject", "value": "Editorials", "is_major": "Y", "rank": "1"}, {"name": "subject", "value": "Drug Abuse and Traffic", "is_major": "Y", "rank": "2"}, {"name": "subject", "value": "Buprenorphine (Drug)", "is_major": "N", "rank": "3"}, {"name": "subject", "value": "OxyContin (Drug)", "is_major": "N", "rank": "4"}, {"name": "organizations", "value": "House of Representatives", "is_major": "N", "rank": "5"}, {"name": "organizations", "value": "Senate", "is_major": "N", "rank": "6"}, {"name": "subject", "value": "Pain-Relieving Drugs", "is_major": "Y", "rank": "7"}], "blog": [], "subsection_name": null, "type_of_material": "Editorial"}